News

• Reduced renal events with a gliclazide
• Published on Jan 19, 2012

Treatment with an intensive glucose control regimen based on modified-release gliclazide reduces major renal events, according to new results from the ADVANCE trial.

• Insulin analogue improves glucose control
• Published on Jan 19, 2012

Patients with type 2 diabetes starting on insulin analogue treatment showed improved glucose control and low rates of hypoglycaemia, according to results from the A1chieve study.

• One-year study shows benefit of CGM
• Published on Jan 19, 2012

Continuous glucose monitoring enables patients with poorly controlled type 1 diabetes to achieve sustained reductions in HbA1c that average 0.5% lower than usual self-monitoring, according to results from a one-year study.

• CV events in sitagliptin vs sulphonylurea
• Published on Jan 19, 2012

The incidence of cardiovascular events in patients with type 2 diabetes treated with the DPP-4 inhibitor sitagliptin is significantly lower than in those treated with sulphonylureas, according to a pooled analysis.

• New type 1 diabetes genes unravelled
• Published on Nov 07, 2011

Researchers from the Children’s Hospital of Philadelphia have identified a new group of genetic differences that may increase the risk of developing type 1 diabetes.